44698 Federal Register / Vol. 71, No. 151 / Monday, August 7, 2006 / Notices 

Federal Communications Commission. 

Marlene H. Dortch, 

Secretary. 

[FR Doc. 06–6757 Filed 8–3–06; 12:40 pm] 

BILLING CODE 6712–01–P 

FEDERAL HOUSING FINANCE BOARD 

Sunshine Act Meeting Notice; 

Announcing a Partially Open Meeting 

of the Board of Directors 

TIME AND DATE: The open meeting of the 

Board of Directors is scheduled to begin 

at 10 a.m. on Wednesday, August 9, 

2006. The closed portion of the meeting 

will follow immediately the open 

portion of the meeting. 

PLACE: Board Room, First Floor, Federal 

Housing Finance Board, 1625 Eye 

Street, NW., Washington, DC 20006. 

STATUS: The first portion of the meeting 

will be open to the public. The final 

portion of the meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED AT THE OPEN

PORTION: Data Reporting Requirements: 

Affordable Housing Program. 

Proposed Bank Examination Rating 

System. 

MATTER TO BE CONSIDERED AT THE CLOSED

PORTION: Periodic Update of 

Examination Program Development and 

Supervisory Findings. 

CONTACT PERSON FOR MORE INFORMATION: 

Shelia Willis, Paralegal Specialist, 

Office of General Counsel, at 202–408–

2876 or williss@fhfb.gov. 

Dated: August 2, 2006. 

By the Federal Housing Finance Board. 

John P. Kennedy, 

General Counsel. 

[FR Doc. 06–6748 Filed 8–3–06; 9:33 am] 

BILLING CODE 6725–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Government-Owned Inventions: 

Availability for Licensing 

AGENCY: National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention. 

Technology Transfer Office, Department 

of Health and Human Services. 

ACTION: Notice. 

SUMMARY: The invention named in this 

notice is owned by agencies of the 

United States Government and is 

available for licensing in the United 

States (U.S.) in accordance with 35 

U.S.C. 207, to achieve expeditious 

commercialization of results of federally 

funded research and development. This 

opportunity is available until 30 days 

after publication of this notice. 

Respondents may be provided a longer 

period of time to furnish additional 

information if CDC/NIOSH finds this 

necessary. 

ADDRESSES: Licensing information may 

be obtained by contacting Thomas 

O’Toole, Chief Licensing Officer, 

Technology Transfer Office, Centers for 

Disease Control and Prevention (CDC), 

Mailstop K–79, 4770 Buford Highway, 

Atlanta, GA 30341, telephone (770) 

488–8600; facsimile (770) 488–8615. 

Information related to the listed 

technology, may be obtained by 

contacting Eric Zahl, Civil Engineer, 

Spokane Research Laboratory, National 

Institute for Occupational Safety and 

Health (NIOSH), Centers for Disease 

Control and Prevention (CDC), 315 E. 

Montgomery Avenue, Spokane, WA 

99207, telephone (509) 354–8020; or email EZahl@cdc.gov. 

Occupational Safety Device—Mobile 

Manipulator System (MMS): NIOSH 

researchers have developed a Mobile 

Manipulator System (MMS), a prototype 

lifting device that enables one person to 

lift and maneuver up to 600 pound 

loads. The MMS is a utility device, 

designed to reduce lifting accidents 

among maintenance personnel 

associated with the manual handling of 

equipment and materials. Prototype 

specifications, capabilities, photos, 

video clips, and further details may be 

viewed online at http://www.cdc.gov/ 

niosh/mining/products/product147.htm. 

CDC/NIOSH is seeking licensing 

partner(s) to refine development of this 

system and commercialize the final 

product. Preferred partners should have 

a strong market share and a 

demonstrated business network capable 

of effective dissemination and customer 

support for the final product. Partners 

should also have: (1) Expertise in 

developing safe and effective material 

handling equipment for the U.S. 

markets and (2) evidence of 

manufacturing similar types of 

equipment for wide-spread distribution 

throughout U.S. markets in an 

expeditious manner. 

Companies interested in the 

opportunity should submit a proposal of 

five pages or less to: Eric Zahl, Civil 

Engineer, Spokane Research Laboratory, 

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC), 

315 E. Montgomery Avenue, Spokane, 

WA 99207, telephone (509) 354–8020; 

or e-mail EZahl@cdc.gov. 

Inventors: Clark, Curtis. 

U.S. Patent Application SN: 10/485,706 

filed 2/2/2004 and PCT/US02/24542. 

(CDC Ref. #: I–018–01 & I–029–05) 

Dated: July 31, 2006. 

James D. Seligman, 

Chief Information Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E6–12734 Filed 8–4–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Discussions Regarding Exotic Animal 

Importation, Sale, and Distribution: 

Summary of Information Presented at 

Public Meeting 

AGENCY: Centers for Disease Control and 

Prevention, Department of Health and 

Human Services. 

ACTION: Notice; Summary of information 

presented at public meeting. 

SUMMARY: On May 18, 2006, CDC hosted 

a public meeting on the subject of 

infectious disease threats associated 

with exotic animal importation and 

trade. CDC announced the public 

meeting through a Federal Register 

notice on April 20, 2006 (Volume 71, 

Number 76, Page 20402–20403). The 

public meeting was held at 130 

Clairemont Ave., Decatur, GA 30030, 

from 1 p.m. to 5 p.m. 

Background: Zoonoses are diseases 

that can be transmitted from animals to 

people. Wild exotic animals may carry 

a variety of known and emerging 

zoonotic pathogens. The American 

Veterinary Medical Association 

(AVMA), the Council of State and 

Territorial Epidemiologists (CSTE), and 

the National Association of State Public 

Health Veterinarians (NASPHV) have 

issued position statements calling for a 

coordinated federal approach to better 

control infectious disease risks 

associated with the exotic animal trade. 

To gather information on the topic, CDC 

organized this public meeting to share 

information concerning infectious 

disease risks associated with exotic 

animal importation and trade. 

Meeting Summary: Five panelists 

were present to answer potential 

questions generated by public 

comments; these panelists represented 

NASPHV, HHS/CDC, the United States 

Department of Agriculture (USDA) 

Animal and Plant Health Inspection 

Service (APHIS) Animal Care, HHS/ 


sroberts on PROD1PC70 with NOTICES